Effects of physiological increases of plasma noradrenaline on gastric acid secretion and gastrointestinal hormones

Digestive Diseases and Sciences - Tập 32 - Trang 715-719 - 1987
H. Graffner1,2,3,4, S. R. Bloom1,2,3,4, L. -O. Farnebo1,2,3,4, J. Järhult1,2,3,4
1Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden
2Department of Surgery, Danderyd, Sweden
3Department of Surgery, Eksjö, Sweden
4Department of Medicine, Hammersmith Hospital, London, England.

Tóm tắt

It is not known if the increased plasma concentration of noradrenaline in patients with chronic duodenal ulcer disease is a pathogenetic factor or not. The aim of the present study was to investigate if physiologic changes of noradrenaline would evoke any alterations in gastric acid secretion or in the plasma concentration of some gastrointestinal hormones (gastrin, secretin, PP, PYY, and GIP) known to affect gastric physiology. The results show that basal plasma noradrenaline concentration was 1.8 nM and after infusion with noradrenaline at 0.04 or 0.2 nmol/kg/min plasma levels of 2.5 and 4.4 nM were obtained. No appreciable changes could be found in basal or pentagastrin stimulated acid secretion or in any of the gastrointestinal peptides studied. If the elevated plasma noradrenaline concentration observed in duodenal ulcer patients is a pathogenetic factor; it is probable that it interferes with other variables such as blood flow, bicarbonate secretion, or prostaglandin synthesis.

Tài liệu tham khảo

Brandsborg O, Brandsborg M, Lövgreen N, Christensen N: Increased plasma noradrenaline and serum gastrin in patients with duodenal ulcer. Eur J Clin Invest 8:11–14, 1978 Järhult J, Angerås U, Farnebo L-O, Graffner H, Hamberger B: Elevated plasma levels of noradrenaline in duodenal ulcer. World J Surg 7:385–389, 1983 Bekker C, Andersen D, Kronborg O, Madsen P, Johansen T, Christiansen L: Plasma catecholamine and serum gastrin concentrations during sham feeding. Life Sci 32:257–262, 1983 Leonsins A, Waddell W: Inhibiting effect of norepinephrine on gastric secretion in human subjects. J Appl Physiol 12:334–348, 1958 Christensen K, Stadil F: Effect of epinephrine and norepinephrine on gastrin release and gastric secretion of acid in man. Scand J Gastroenterol (Suppl) 37:87–92, 1976 Järhult J, Farnebo L-O, Hamberger B, Holst J, Schwartz T: The relation between catecholamines, glucagon and pancreatic polypeptide during hypoglycaemia in man. Acta Endocrinol 98:402–406, 1981 Hökfelt B, Hansson BG, Heding L, Nilsson KO: Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, cortisol, c-peptide, and proinsulin before and during medication with the cardioselective B-receptor blocking agent metoprolol in man. Acta Endocrinol 87:659–667, 1978 Järhult J, Hamberger B, Lanthén G, Ors M, Uvnäs-Wallensten K: The role of catecholamines in the control of gastrin and acid secretion during insulin hypoglycaemia in man. Digestion 21:92–97, 1981 Hostein J, Fournet J, Debru J, Bonnet-Eymard J: Action of norepinephrine on the serum gastrin level. Digestion 18:134–137, 1978 Lundberg J, Hökfelt T, Änggård A, Terenius L, Elde R, Markey K, Goldstein M, Kimmel J: Organizational principles in the peripheral sympathetic nervous system: Subdivision by coexisting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials). Proc Natl Acad Sci USA 79:1303–1307, 1977 Larson GM, Sullivan HW, O'Dorisio T: Surgical sympathectomy increases pancreatic polypeptide response to food. Surgery 98:236–242, 1985 Salera M, Ebert R, Giacomoni P, Pironi L, Venturi S, Corinaldesi R, Miglioli M, Barbara L: Adrenergic modulation of gastric inhibitory polypeptide secretion in man. Dig Dis Sci 27:794–800, 1982 Koop H, Behrens I, Bothe E, Koschwitz H, McIntosh CHS, Pederson RA, Arnold R, Creutzfeldt W: Adrenergic control of rat gastric somatostatin and gastrin release. Scand J Gastroenterol 19:65–71, 1983 Hallman H, Farnebo LO, Hamberger B, Jonsson G: A sensitive method for the determination of plasma catecholamines using liquid chromotography with electrochemical detection. Life Sci 23:1049–1052, 1978 Bloom SR, Long RG: Radioimmunoassay of Gut Regulatory Peptides. Eastbourne, WB Saunders, 1982 Adrian TE, Ferri G-L, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070–1077, 1985 Åkerstedt T, Gillberg M, Hjemdahl P, Sigurdson K, Gustavsson I, Daleskog M, Tollare T: Comparison of urinary and plasma catecholamine responses to mental stress. Acta Physiol Scand 117:19–26, 1983 Jacobson ED: Comparison of prostaglandin E1 and norepinephrine on the gastric mucosal circulation. Proc Soc Exp Biol Med 133:516–519, 1970 Brandsborg O, Brandsborg M, Christensen N: Plasma adrenaline and serum gastrin: Studies in insulin-induced hypoglycemia and after adrenaline infusions. Gastroenterology 68:455–460, 1975 Brandsborg O, Christensen N, Galbo H, Brandsborg M, Lövgreen N: The effect of exercise, smoking and propranolol on serum gastrin in patients with duodenal ulcer and in vagotomized subjects. Scand J Clin Lab Invest 38:441–446, 1978 Kaess H, Utz G, Teckentrupp U, Hauck A, Dörner M: Effect of propranolol and phentolamine on serum gastrin concentration in response to respiratory acidosis in normal man. Eur J Invest 5:401–408, 1975 Russell RCG, Bloom SR, Fielding LP, Bryant MG: Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J 52:645–650, 1976 Schwartz TW, Stadil F, Chance RE, Rehfeld JF, Larsson LI, Moon N: Pancreatic polypeptide response to food in duodenal ulcer patients before and after vagotomy. Lancet 1:1102–1105, 1976 Schwartz TW: Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85:1411–1425, 1983 Flaten O, Myren J: Adrenergic modulation of the release of pancreatic polypeptide after intraduodenal and oral glucose in man. Scand J Gastroenterol 16:781–787, 1981 Linnestad P, Guldvog I, Schrumpf E: The effect of alphaand beta-adrenergic agonists and blockers on postprandial pancreatic polypeptide release in dogs. Scand J Gastroenterol 18:87–90, 1983 Kayasseh L, Haecki WH, Gyr K, Stalder GA, Rittman, WW, Halter F, Girard J: The endogenous release of pancreatic polypeptide by acid and meal in dogs. Scand J Gastroenterol 13:385–391, 1978 Makhlouf GM, Zfass AM, Said SI, Schebalin M: Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences on gastric secretion. Proc Soc Exp Biol Med 157:565–568, 1978 McLoughlin JC, Hayes JR, Buchanan KD, Kelly JG: Role of neural influences in the release of gastrin, glucagon and secretin during hypoglycaemia in man. Gut 19:632–639, 1978 Sirinek KR, Cataland S, O'Dorisio T, Mazzaferri EL, Crockett S, Pace WG: Sympathetic neuroendocrine regulation of gastric inhibitory polypeptide response to glucose. Surg Forum 28:377–379, 1977 Jacobowitz D, Olschowka J: Bovine pancreatic polypeptidelike immunoreactivity in brain and peripheral nervous system: Coexistence with catecholaminergic nerves. Peptides 3:569–590, 1982 Adrian TE, Sagor GR, Savage AP: Low dose PYY inhibits gastric secretion in man. Gut 24:A479, 1983 Flemström G, Turnberg LA: Gastroduodenal defence mechanisms. Clin Gastroenterol 13:327–354, 1984 Hedqvist P, Gustafsson L, Hjemdahl P, Svanborg K: Aspects of prostaglandin action on autonomic neuroeffector transmission.In Advances in Prostaglandin and Thromboxane Research, Vol 8. B Samuelsson, PW Ramwell, R Paoletti (eds). New York, Raven Press, 1980, pp 1245–1248